| 45.725 -0.285 (-0.62%) | 09-04 12:07 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 54.22 | 1-year : | 63.33 |
| Resists | First : | 46.42 | Second : | 54.22 |
| Pivot price | 45.71  |
|||
| Supports | First : | 44.18 |
Second : | 42.8 |
| MAs | MA(5) : | 45.72 |
MA(20) : | 45.35 |
| MA(100) : | 41.33 |
MA(250) : | 39.24 |
|
| MACD | MACD : | 0.6 |
Signal : | 0.7 |
| %K %D | K(14,3) : | 73.5 |
D(3) : | 72.1 |
| RSI | RSI(14): 60.3 |
|||
| 52-week | High : | 46.42 | Low : | 33.49 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ BME ] has closed above bottom band by 43.7%. Bollinger Bands are 18.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 46.23 - 46.42 | 46.42 - 46.61 |
| Low: | 45.22 - 45.41 | 45.41 - 45.61 |
| Close: | 45.69 - 46.03 | 46.03 - 46.38 |
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Sun, 30 Aug 2026
Blackrock Health Sciences Trust (BME) Peer Comparison – Compare with Others - Value Research
Sat, 29 Aug 2026
Blackrock Health Sciences Trust (BME) Key Financial Ratios – Valuation, Profitability & More - Value Research
Fri, 28 Aug 2026
Blackrock Health Sciences Trust (BME) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Mon, 24 Aug 2026
BlackRock Health Sciences Trust underperforms p... - Pluang
Mon, 24 Aug 2026
Healthcare Is Rising: XLV Is A Better Option For Investors Than BME (NYSEARCA:XLV) - Seeking Alpha
Mon, 17 Aug 2026
Blackrock Health Sciences Trust (BME) Advances 0.59% to $44.4 as Healthcare Sector Finds Footing - Retail Sentiment - vinanet.vn
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 20 (%) |
| Shares Short | 37 (K) |
| Shares Short P.Month | 60 (K) |
| EPS | 5.92 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 43.97 |
| Profit Margin | 994.9 % |
| Operating Margin | 20.2 % |
| Return on Assets (ttm) | 0.1 % |
| Return on Equity (ttm) | 13.8 % |
| Qtrly Rev. Growth | 7.5 % |
| Gross Profit (p.s.) | 0.59 |
| Sales Per Share | 0.59 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 55 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | 7.7 |
| PEG Ratio | 0 |
| Price to Book value | 1.03 |
| Price to Sales | 76.1 |
| Price to Cash Flow | 0 |
| Dividend | 0.25 |
| Forward Dividend | 0 |
| Dividend Yield | 0.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|